Venmax Drugs Allots 28 Lakh Shares via Warrant Conversion

Venmax Drugs allotted 28,00,000 equity shares at Rs. 20 each to two non-promoter warrant holders on March 23, 2026.
Balance exercise price of Rs. 15 per warrant (75% of issue price) was received, aggregating to Rs. 4.20 crore inflow.
Post-allotment paid-up capital rose to Rs. 11,58,29,300 comprising 1,15,82,930 equity shares of Rs. 10 face value.
36,81,000 fully convertible warrants remain outstanding out of original 1,00,25,000 warrants issued on March 20, 2025.